Kim Ely, MD, is a graduate of Massachusetts Institute of Technology and Tulane University School of Medicine. After completing her AP/CP residency at Wake Forest University, she pursued fellowship training at Vanderbilt University Medical Center and subsequently joined the faculty as a cytopathologist and head and neck surgical pathologist. Currently, she is an Associate Professor, serving as the Director of Cytopathology and the Cytopathology Fellowship Training program. As a member of the Cytopathology Program Directors Committee of the American Society of Cytopathology (ASC), she has been instrumental in the development of the unified timeline for cytopathology fellowship recruitment, as well as the Strategies in Cytology Education Cytopathology Sessions. She has recorded CytoPathPodcasts on ‘Cytopathology Fellowship Toolkit: Practicing Wellness’ and ‘Cytopathology and LGBTQI Health. In addition to publishing on establishing inclusive cancer screening programs for LGBT+ patients, she recently presented a course at the ASC Companion Meeting for CAP on ‘Cytopathology and LGBTI Health: From Neovaginas to Anal Paps!’ and will give a session at the ASC on “Cytologic Cancer Screening for LGBT + Patients: Morphologic Features and Pitfalls. Active in Vanderbilt’s Cervical Cancer Screening Task Force, Dr. Ely also sits on the Editorial Review Board of Cancer Cytopathology and PathologyOutlines and has published and held workshops on Molecular Testing of Follicular Thyroid Neoplasms, ‘A Multidisciplinary Approach to Pediatric Thyroid Nodules,’ ‘Wnt Signaling in Thyroid Homeostasis and Carcinogenesis,’Use of the Thyroid imaging, Reporting, and Data System (TI-RADS) scoring system for the evaluation of subcentimeter thyroid nodules.